Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
BROOKS LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 3.85-41.80-15.630.67

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 3.85 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20243.85
Mar2023-41.80
Mar2022-15.63
Mar20210.67

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2024 3.85
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63
Negative
Mar2021 0.67 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹448.7 Cr -4.8% 1.4% 71.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,595.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹174,635.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹126,894.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,685.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,373.0 Cr 1.4% -3.3% -7.2% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-4.8%

1.4%

71.7%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses